ArticleParasites, hosts and diseases2025
Microarray-based characterization of airway inflammation induced by environmental Acanthamoeba exposure versus the ovalbumin-alum model.
Article in Parasites, hosts and diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Acanthamoeba profilin as a novel airway allergen with diverse sensitization patterns including pollen cross-reactivity.Parasites, hosts and diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ovalbumin (OVA)-alum mouse model, which induces a Th2-biased immune response, is commonly used to study allergic airway inflammation. However, the artificial nature of this model limits its relevance to environmental or infection-related airway diseases. The free-living environmental protozoan Acanthamoeba is a potential trigger of airway inflammation, but its immune mechanisms remain largely unknown. To compare these 2 models of airway inflammation, this study carried out microarray-based transcriptomic analysis of lung tissue obtained from mice with OVA-alum treatment or intranasal Acanthamoeba exposure. Compared to controls, OVA-alum treatment induced broad transcriptional changes involving >2,900 probes (fold change ≥1.5); Acanthamoeba exposure led to a substantially weaker response, with <500 probes affected at the same threshold. Unlike the OVA-alum-treated group, the Acanthamoeba-exposed mice showed minimal overlap with only 5 genes significantly downregulated, suggesting a distinct immune activation profile. Downregulation of genes related to the immunoglobulin variable region (Ighv1-58 and Igkv3-10) and eosinophil function (Rnase2a) in the Acanthamoeba group suggest suppression of a typical Th2/humoral response. Heatmap and clustering analysis demonstrated clear separation between the Acanthamoeba, OVA-alum, and control groups. Taken together, these results suggest that Acanthamoeba induces a unique airway immune response that is markedly different from traditional Th2-dominant inflammation, and may be a more suitable model for studying environmentally-induced or infection-related respiratory diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.